心脏磁共振在心肌梗死微血管阻塞及心肌出血中的应用

马敏; 祝烨; 贺勇

doi:10.13201/j.issn.1001-1439.2016.08.002

心脏磁共振在心肌梗死微血管阻塞及心肌出血中的应用

- 1 成都市第六人民医院心内科(成都, 610051);
- 2 四川大学华西医院心内科(成都, 610041)

详细信息

通讯作者: 贺勇,E-mail:zznnyeah@163.com

中图分类号: R542.2

收稿日期: 2016-04-01

Application of cardiac MRI in microvascular obstruction and myocardial hemorrhage after myocardial infarction

- 1 Department of Cardiology, The Sixth People's Hospital of Chengdu, 610051, China;
- 2 Department of Cardiology, West China Hospital of Sichuan University, Chengdu, 610041, China

More Information

Corresponding author: HE Yong, E-mail: zznnyeah@163.com

Received Date: 01 April 2016

摘要

摘要: 微血管阻塞或无复流现象是急性心肌梗死行冠状动脉再灌注治疗中常见的并发症。这种现象是不良预后的征象,亦是导致不良左心室重构的原因。尽管微血管病变可以通过心电图、心肌声学造影、核素扫描及冠状动脉造影等检查,但远没有心脏磁共振有效、全面。微血管病变的评估已经成为了心肌梗死行再灌注治疗后效果评价及指导药物治疗的重要辅助手段。本文就微血管的病理生理,心脏磁共振用于该病变的诊断、临床意义及将来发展方向作一综述。
- 微血管阻塞 /
- 心肌梗死 /
- 心脏磁共振 /
- 心肌出血
Abstract: Microvascular obstruction and no reflow phenomenon are the common complications in coronary reperfusion after acute myocardial infarction.They induce left ventricular remodeling and indicate the adverse prognosis.Microvascular lesions are assessed by cardiac magnetic resonance imaging comprehensively.In this review,we demonstrate the diagnosis,clinical significance and progress of cardiac magnetic resonance imaging application in coronary microvascular diseases post myocardial infarction.
- microvascular obstruction /
- myocardial infarction /
- cardiac magnetic resonance imaging /
- myocardial hemorrhage

HTML全文

参考文献(53)

[1]	KLONER R A,GANOTE C E,JENNINGS R B.The"no-reflow"after temporary coronary occlusion in the dog[J].J Clin Invest,1974,54:1496-1508.
[2]	REFFELMANN T,KLONER R A.The"no-reflow"phenomenon:basic science and clinical correlates[J].Heart,2002,87:162-168.
[3]	REFFELMANN T,KLONER R A.The no-reflow phenomenon:a basic mechanism of myocardial ischemia and reperfusion[J].Basic Res Cardiol,2006,101:359-372.
[4]	PIPER H M,GARCIA-DORADO D,OVIZE M.A fresh look at reperfusion injury[J].Cardiovasc Res,1998,38:291-300.
[5]	SCHWARTZ LONGACRE L,KLONER R A,ARAI A E,et al.New horizons in cardioprotection:recommendations from the 2010 National Heart,Lung,and Blood Institute Workshop[J].Circulation,2011,124:1172-1179.
[6]	YE Y X,BASSE-LÜSEBRINK T C,ARIAS-LOZA P A,et al.Monitoring of monocyte recruitment in reperfused myocardial infarction with intramyocardial hemorrhage and microvascular obstruction by combined fluorine 19and proton cardiac magnetic resonance imaging[J].Circulation,2013,128:1878-1888.
[7]	ROCHITTE C E,LIMA J A,BLUEMKE D A,et al.Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction[J].Circulation,1998,98:1006-1014.
[8]	BEKKERS S C,BACKES W H,KIM R J,et al.Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging[J].Eur Radiol,2009,19:2904-2912.
[9]	KIM R J,FIENO D S,PARRISH T B,et al.Relationship of MRI delayed contrast enhancement to irreversible injury,infarct age,and contractile function[J].Circulation,1999,100:1992-2002.
[10]	SHISHIDO T,BEPPU S,MATSUDA H,et al.Progression of intramural hemorrhage in the reperfused area:an experimental study assessed by myocardial contrast echocardiography(abstr)[J].Circulation,1993,88(Suppl I):I-02.
[11]	ITO H.No-reflow phenomenon and prognosis in patients with acute myocardial infarction[J].Nat Clin Pract Cardiovasc Med,2006,3:499-506.
[12]	FISHBEIN M C,Y-RIT J,LANDO U,et al.The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion[J].Circulation,1980,62:1274-1279.
[13]	KLONER R A,ALKER K J.The effect of streptokinase on intramyocardial hemorrhage,infarct size,and the no-reflow phenomenon during coronary reperfusion[J].Circulation,1984,70:513-521.
[14]	YELLON D M,HAUSENLOY D J.Myocardial reperfusion injury[J].N Engl J Med,2007,357:1121-1135.
[15]	PISLARU S V,BARRIOS L,STASSEN T,et al.Infarct size,myocardial hemorrhage,and recovery of function after mechanical versus pharmacological reperfusion.Effects of lytic state and occlusion time[J].Circulation,1997,96:659-666.
[16]	KALI A,TANG R L,KUMAR A,et al.Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging:T2 versus T2[J].Radiology,2013,269:387-395.
[17]	LOTAN C S,BOUCHARD A,CRANNEY G B,et al.Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T[J].Circulation,1992,86:1018-1025.
[18]	FOLTZ W D,YANG Y,GRAHAM J J,et al.MRI relaxation fluctuations in acute reperfused hemorrhagic infarction[J].Magn Reson Med,2006,56:1311-1319.
[19]	JACKOWSKI C,CHRISTE A,SONNENSCHEIN M,et al.Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization[J].Eur Heart J,2006,27:2459-2467.
[20]	GERBER B L,ROCHITTE C E,MELIN J A,et al.Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction[J].Circulation,2000,101:2734-2741.
[21]	AMADO L C,KRAITCHMAN D L,GERBER B L,et al.Reduction of"no-reflow"phenomenon by intraaortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study[J].J Am Coll Cardiol,2004,43:1291-1298.
[22]	ASANUMA T,TANABE K,OCHIAI K,et al.Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction:myocardial contrast echocardiographic study[J].Circulation,1997,96:448-453.
[23]	SAKUMA T,HAYASHI Y,SHIMOHARA A,et al.Usefulness of myocardial contrast echocardiography for the assessment of serial changes in risk area in patients with acute myocardial infarction[J].Am J Cardiol,1996,78:1273-1277.
[24]	REFFELMANN T,HALE S L,DOW J S,et al.No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion[J].Circulation,2003,108:2911-2917.
[25]	LUO A K,WU K C.Imaging microvascular obstruction and its clinical significance following acute myocardial infarction[J].Heart Fail Rev,2006,11:305-312.
[26]	BOLOGNESE L,CARRABBA N,PARODI G,et al.Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction[J].Circulation,2004,109:1121-1126.
[27]	ITO H,MARUYAMA A,IWAKURA K,et al.Clinical implications of the 'no reflow' phenomenon.a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction[J].Circulation,1996,93:223-228.
[28]	NDREPEPA G,TIROCH K,FUSARO M,et al.5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction[J].J Am Coll Cardiol,2010,55:2383-2389.
[29]	REZKALLA S H,DHARMASHANKAR K C,ABDALRAHMAN I B,et al.No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction:incidence,outcome,and effect of pharmacologic therapy[J].J Interv Cardiol,2010,23:429-436.
[30]	BODI V,SANCHIS J,NUNEZ J,et al.Prognostic value of acomprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction[J].JACC Cardiovasc Imaging,2009,2:835-842.
[31]	LAROSE E,RODES-CABAU J,PIBAROT P,et al.Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction,salvaged myocardium,and necrosis characteristics by cardiovascular magnetic resonance[J].J Am Coll Cardiol,2010,55:2459-2546.
[32]	WU K C.Variation on a theme:CMR as the"onestop shop"for risk stratification after infarction?[J].JACC Cardiovasc Imaging,2009,2:843-845.
[33]	REFFELMANN T,KLONER R A.Microvascular reperfusion injury:rapid expansion of anatomic no reflow during reperfusion in the rabbit[J].Am J Physiol Heart Circ Physiol,2002,283:H1099-2007.
[34]	FUJIWARA H,ONODERA T,TANAKA M,et al.A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase[J].Circulation,1986,73:749-757.
[35]	BRAUNWALD E,KLONER R A.Myocardial reperfusion:a double-edged sword?[J].J Clin Invest,1985,76:1713-1719.
[36]	MASSEL D R.How sound is the evidence that thrombolysis increases the risk of cardiac rupture?[J].Br Heart J,1993,69:284-287.
[37]	KLONER R A,ALKER K,CAMPBELL C,et al.Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?[J].Circulation,1989,79:1125-1136.
[38]	ANZALONE N,SCOTTI R,RIVA R.Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage[J].Neurol Sci,2004,25 Suppl 1:S3-5.
[39]	BRADLEY W G Jr:MR appearance of hemorrhage in the brain[J].Radiology,1993,189:15-26.
[40]	BASSO C,CORBETTI F,SILVA C,et al.Morphologic validation of reperfused hemorrhagic myocardial infarction bycardiovascular magnetic resonance[J].Am J Cardiol,2007,100:1322-1327.
[41]	MIKAMI Y,SAKUMA H,NAGATA M,et al.Relation between signal intensity on T2-weighted MR images and presence of microvascular obstruction in patients with acute myocardial infarction[J].AJR Am J Roentgenol,2009,193:W321-326.
[42]	CANNAN C,EITEL I,HARE J,et al.Hemorrhage in the myocardium following infarction[J].JACC Cardiovasc Imaging,2010,3:665-668.
[43]	GIRI S,CHUNG Y C,MERCHANT A,et al.T2 quantification for improved detection of myocardial edema[J].J Cardiovasc Magn Reson,2009,11:56-60.
[44]	VERHAERT D,THAVENDIRANATHAN P,GIRI S,et al.Direct T2 quantification of myocardial edema in acute ischemic injury[J].JACC Cardiovasc Imaging,2011,4:269-278.
[45]	GHUGRE N R,RAMANAN V,POP M,et al.Quantitative tracking of edema,hemorrhage,and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI[J].Magn Reson Med,2011,66:1129-1141.
[46]	O'REGAN D P,ARIFF B,NEUWIRTH C,et al.Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction[J].Heart,2010,96:1885-1891.
[47]	TARANTINI G,FAVARETTO E,NAPODANOM,et al.Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction(POST-AMI)trial[J].Cardiology,2010,116:110-116.
[48]	LUDMAN A J,YELLON D M,HASLETON J,et al.Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention:a randomised controlled clinical trial[J].Heart,2011,97:1560-1565.
[49]	PATEL M R,SMALLING R W,THIELE H,et al.Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock:the CRISP AMI randomized trial[J].JAMA,2011,306:1329-1337.
[50]	DILL T,SCHACHINGER V,ROLF A,et al.Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute STsegment elevation myocardial infarction:results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study(REPAIR-AMI)cardiac magnetic resonance imaging substudy[J].Am Heart J,2009,157:541-547.
[51]	HIRSCH A,NIJVELDT R,VAN DER VLEUTEN P A,et al.Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention:results of the randomized controlled HEBE trial[J].Eur Heart J,2011,32:1736-1747.
[52]	WOHRLE J,MERKLE N,MAILANDER V,et al.Results of intracoronary stem cell therapy after acute myocardial infarction[J].Am JCardiol,2010,105:804-812.
[53]	GRIEVE S M,BHINDI R,SEOW J,et al.Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance[J].Circ Heart Fail,2011,3:e5-6.